1. Home
  2. SVII vs AMRN Comparison

SVII vs AMRN Comparison

Compare SVII & AMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SVII
  • AMRN
  • Stock Information
  • Founded
  • SVII 2021
  • AMRN 1989
  • Country
  • SVII United States
  • AMRN Ireland
  • Employees
  • SVII N/A
  • AMRN N/A
  • Industry
  • SVII Blank Checks
  • AMRN Biotechnology: Pharmaceutical Preparations
  • Sector
  • SVII Finance
  • AMRN Health Care
  • Exchange
  • SVII Nasdaq
  • AMRN Nasdaq
  • Market Cap
  • SVII 248.9M
  • AMRN 234.4M
  • IPO Year
  • SVII 2022
  • AMRN 1993
  • Fundamental
  • Price
  • SVII $11.30
  • AMRN $0.60
  • Analyst Decision
  • SVII
  • AMRN Hold
  • Analyst Count
  • SVII 0
  • AMRN 3
  • Target Price
  • SVII N/A
  • AMRN $1.00
  • AVG Volume (30 Days)
  • SVII 14.2K
  • AMRN 685.0K
  • Earning Date
  • SVII 01-01-0001
  • AMRN 10-30-2024
  • Dividend Yield
  • SVII N/A
  • AMRN N/A
  • EPS Growth
  • SVII 36.87
  • AMRN N/A
  • EPS
  • SVII 0.37
  • AMRN N/A
  • Revenue
  • SVII N/A
  • AMRN $264,779,000.00
  • Revenue This Year
  • SVII N/A
  • AMRN N/A
  • Revenue Next Year
  • SVII N/A
  • AMRN N/A
  • P/E Ratio
  • SVII $30.53
  • AMRN N/A
  • Revenue Growth
  • SVII N/A
  • AMRN N/A
  • 52 Week Low
  • SVII $10.72
  • AMRN $0.56
  • 52 Week High
  • SVII $11.30
  • AMRN $1.37
  • Technical
  • Relative Strength Index (RSI)
  • SVII 81.34
  • AMRN 46.31
  • Support Level
  • SVII $11.20
  • AMRN $0.57
  • Resistance Level
  • SVII $11.23
  • AMRN $0.62
  • Average True Range (ATR)
  • SVII 0.01
  • AMRN 0.02
  • MACD
  • SVII 0.01
  • AMRN 0.00
  • Stochastic Oscillator
  • SVII 100.00
  • AMRN 36.56

About SVII Spring Valley Acquisition Corp. II

Spring Valley Acquisition Corp II is a blank check company.

About AMRN Amarin Corporation plc

Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.

Share on Social Networks: